Abstract:The phenomenon of protein aggregation into amyloid fibrils is associated with a large number of major diseases of unrelated etiology. Unraveling the mechanism of amyloid self-assembly and identifying therapeutic directions to control this process are of utmost importance. Research in this field has been hampered by several challenges, including reproducibility, low protein purification yields, and the inherent aggregation propensity of amyloidogenic proteins, making them extremely difficult to study. Herein, on the basis of the similarity in the assembly mechanism, as well as the physical, chemical, and biological characteristics, of diphenylalanine nanostructures and aromatic amino acid containing amyloid fibrils, we report a simple, yet robust peptide-based platform that could be used for screening of small molecules potentially capable of interfering with the aggregation process and for mechanistic exploration of their mode of action. The system was validated using four small-molecule inhibitors, and the effect was examined via turbidity assay, thioflavin T fluorescence, and electron microscopy. The aggregation profile of diphenylalanine was very similar to that of β-amyloid polypeptide in the presence of the modulators. Rosmarinic acid emerged as an extremely potent inhibitor and a destabilizer of the aggregates. The effect of stoichiometric variation of rosmarinic acid on the process of destabilization was also probed using a microfluidic technique. Finally, the formation of equimolar complexes of diphenylalanine and inhibitors was detected using mass spectrometry. This approach not only provides a system for high-throughput screening of possible inhibitor molecules from larger libraries of modulators, but is also highly useful for understanding the mechanistic aspects of the interactions leading to the process of inhibition.

A rapid in vivo pipeline to identify small molecule inhibitors of amyloid aggregation

A Rapid Pipeline to Identify Small Molecule Inhibitors of Amyloid Aggregation

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Screening Carbon Nano Materials for Preventing Amyloid Protein Aggregation by Adopting a Facile Method

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

Structure-Based Peptide Inhibitor Design of Amyloid-β Aggregation

General Aggregation-Induced Emission Probes for Amyloid Inhibitors with Dual Inhibition Capacity Against Amyloid Β-Protein and Α-Synuclein.

Α-Helical Motif As Inhibitors of Toxic Amyloid-β Oligomer Generation Via Highly Specific Recognition of Amyloid Surface

Structure‐based Virtual Screening and Biological Characterization of Novel BACE‐1 and Amyloid‐β Aggregation Inhibitors

Diphenylalanine as a Reductionist Model for the Mechanistic Characterization of β-Amyloid Modulators

Macromolecular and small-molecule modulation of intracellular Aβ42 aggregation and associated toxicity.

Accelerating Protein Aggregation and Amyloid Fibrillation for Rapid Inhibitor Screening

Rational design of a high-affinity fluorescent probe for visualizing monitoring the amyloid β clearance effect of anti-Alzheimer's disease drug candidates

A Chemical Perspective to the Anti-Amyloid Action of Compounds and a Nanoparticle Based Assay for Screening Amyloid Inhibitors

In Vivo Mitigation of Amyloidogenesis through Functional-Pathogenic Double-Protein Coronae

Molecular engineering of a theranostic molecule that detects Aβ plaques, inhibits Iowa and Dutch mutation Aβ self-aggregation and promotes lysosomal biogenesis for Alzheimer's disease

Small-Molecule Amyloid Beta-Aggregation Inhibitors in Alzheimer's Disease Drug Development

Application of a Yeast Two-Hybrid Based Screening System in the Identification of Amyloid-Beta Aggregation Inhibitors in Pharmaceutical Plants

An in Vitro Paradigm to Assess Potential Anti-Aβ Antibodies for Alzheimer’s Disease

An efficient biochemical method for characterizing and classifying potentially amyloidogenic and therapeutic peptides

Repurposing Anidulafungin for Alzheimer's Disease via Fragment-Based Drug Discovery